Analisi facoltativa del prodotto
Con il tuo consenso utilizziamo analisi limitate e rispettose della privacy per capire quali percorsi di ricerca funzionano. Non usiamo tracker pubblicitari né registrazioni delle sessioni. Puoi modificare questa scelta nelle Preferenze. Leggi la Informativa sulla privacy.
Celanese Corporation's published Strong Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $5.2B | |
|---|---|---|
| Revenue (ttm) | 9.7B | |
| Net income (ttm) | -1.2B | |
| EPS (ttm) | -$10.7 | |
| Shares out | 109.7M | |
| P/E (forward) | 7.2x | |
| Dividend | $0.12 (0.25%) | |
| Volume | 699,949 | |
| Beta | 0.76 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $8.54B | $9.67B | $10.93B | $10.27B | $9.54B | +2.8% |
| Gross profit | $2.68B | $2.38B | $2.58B | $2.34B | $1.95B | -7.6% |
| Operating income | $1.95B | $1.38B | $1.67B | $-720.0M | $-786.0M | — |
| Net income | $1.89B | $1.89B | $1.94B | $-1.54B | $-1.17B | — |
| EPS (diluted) | $16.86 | $17.34 | $17.76 | $-14.11 | $-10.64 | — |
| EBITDA | $2.72B | $2.30B | $2.61B | $503.0M | $335.0M | -40.7% |
| R&D | $86.0M | $112.0M | $146.0M | $130.0M | $125.0M | +9.8% |
| SG&A | $633.0M | $824.0M | $1.08B | $1.03B | $899.0M | +9.2% |
Recent company headlines from major financial publishers.
Global industrial demand and automotive assembly rates rebound robustly, driving strong volume growth for Engineered Materials. Acetyl Chain pricing remains elevated as Western Hemisphere supply chain advantages persist. Rapid debt retirement reduces annual interest expense, accelerating EPS growth and unlocking multiple expansion toward historical peak levels.
Celanese executes on its core operational strategy: modest revenue growth, steady recovery in Engineered Materials margins via footprint actions, and resilient cash generation from the Acetyl Chain. Free cash flow is disciplined and deployed exclusively to debt reduction, steadily lowering financial leverage and driving intrinsic value convergence to $76.31.
| Ke ↓ / g → | 1.5% | 1.8% | 2.0% | 2.3% | 2.5% |
|---|---|---|---|---|---|
| 7.4% | $83.4 | $85.8 | $88.3 | $91.2 | $94.3 |
| 7.9% | $77.7 | $79.7 | $81.8 | $84.2 | $86.7 |
| 8.4% | $72.9 | $74.5 | $76.3 | $78.2 | $80.3 |
| 8.9% | $68.7 | $70.1 | $71.6 | $73.2 | $74.9 |
| 9.4% | $64.9 | $66.1 | $67.4 | $68.8 | $70.3 |
Upcoming earnings date and setup when available.
Il rating riportato dall'edizione di ricerca pubblicata ogni mese. Un rating confronta il prezzo alla data dell'analisi con il valore equo; non indica se la valutazione si è rivelata corretta.
| Anno | gen | feb | mar | apr | mag | giu | lug | ago | set | ott | nov | dic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
